WA L E S M E D I C A S P E C I A L 2 0 1 2
Wales: Unrivalled Connectivity Why Wales Works for Life Sciences Wales Pavilion Directory Company Case Studies M E D I WA L E S I S S U P P O R T E D B Y T H E W E L S H G O V E R N M E N T
WALES medica special
Improve your workflow
● ● ● ●
Single-use High quality Excellent service Delivers the clinical value you need
+44 (0)1792 797910 www.dtrmedical.com Twitter: @dtrmedical DTR SPECIALITIES:
GENERAL & VASCULAR
Your sterile single-use solution, without compromise ENT/MAXFAX
GYNAECOLOGICAL
NEUROSURGICAL
ORTHOPAEDIC
Visit us at Medica, Hall 16, Stand F30
Medica 14 - 17 November 2012 – Messe Düsseldorf, Germany
The Welsh Pavilion: Hall 16 Stand F30 This MediWales “Medica Special” Review is your introduction to the thriving medical technology sector in Wales. It includes editorial from both MediWales - the Welsh life sciences network - and the Welsh Government’s Life Sciences Team, with a directory of all companies attending the trade mission to Medica 2012. Several companies are represented further through case studies, providing a snapshot of some of the most exciting products and services being offered by Welsh medical technology companies.
dedicated to supporting companies in the sector, recognising that international trade is key to companies’ success.
Medica is the world’s largest and leading global exhibition for the medical sector, and has been established for over 40 years. It runs alongside the leading international fair for medical manufacturing supplies, Compamed. Together, Medica and Compamed occupy all 19 halls of the Düsseldorf Exhibition Centre and organisers expect more than 600 exhibitors from over 60 countries.
Representatives Debbie Laubach and Jess Fisher from MediWales, the Welsh life sciences network, will be on hand to support our indigenous companies to network with potential collaborators and distributors. Having been the sector’s network for over 20 years, MediWales generates a unique environment for networking, collaboration and communication between industry, academia and health service members. This is delivered through an active schedule of events and publications supported by the MediWales website and maintained via constant communication with stakeholders. Supported by the Welsh Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales.
This year’s Welsh delegates are supported by the Welsh Government to attend Medica. The most popular trade mission for Welsh life sciences companies, a record 60+ delegates are attending the Medica mission this year. A democratically elected body established in May 1999, the Welsh Government has devolved powers and is responsible for developing and implementing policies in Wales. Life sciences is a priority area for the Welsh Government and they have a team
With their own NHS Wales, the circa three million Welsh inhabitants receive healthcare through seven health boards. This unique and relatively small NHS provides Wales with the opportunity to develop quicker, leaner processes than its neighbours. Products can be trialled quicker, and the unrivalled connectivity between the NHS, companies and academia precipitates innovative product development, delivering better and timely patient care.
MediWales is a founder member of Medilink UK, a national health technology business support organisation that represents the interests of circa 3000 organisations across the UK.
Contents Features Wales: Unrivalled Connectivity Why Wales Works... for Life Sciences Wales Pavilion Directory
4-6 8-9 10-21
Company Case Studies GX Group DTR Medical E2L Products FRIO UK
22 23 24 25
Forum Manager: gwyn.tudor@mediwales.com Operations Manager: debbie.laubach@mediwales.com Comms Manager: jess.fisher@mediwales.com Project Coordinator: charlotte.tyson@mediwales.com Web: www.mediwales.com Telephone: +44 (0)29 2047 3456 7 Schooner Way, Atlantic Wharf, Cardiff CF10 4DZ MediWales Chairman: Mr Greg Baily, Huntleigh The MediWales Medica Special is designed by Teamworks Design and Marketing
WALES medica special
4
Wales: Unrivalled ‘Unrivalled connectivity’ is a unique selling point for Wales’ life sciences sector, and this message is being voiced internationally. As a devolved nation of approximately three million people, with an independent National Health Service (NHS) and a thriving life science industry, Wales is aware of the opportunities being small offers.
The Welsh Government’s Life Sciences Sector Panel is currently exploring the benefits of establishing a new life sciences hub - a physical entity where stakeholders in the sector can meet and do business.
Accessing International trade markets: In order to carry Wales’ message as a location with unrivalled connectivity, Welsh companies are attending missions across the globe with the support of the Welsh Government.
By Jess Fisher, MediWales Already this year there have been missions to:
Developing the Welsh brand Selling Wales abroad extends beyond the individual company. MediWales has been working with Welsh Government and our Life Science Expert Advisory Group (LSEAG) to succinctly voice what makes Wales unique as a place to work in life sciences: We are small – the proximity between organisations means we can network easily, which can dramatically reduce the cost of doing business and speed up the delivery of new products and services. We are devolved – giving us the power to work on our companies’ needs within a purely Welsh context. We have a devolved NHS – allowing for a faster single coordinated permissions process and improving access to clinical expertise. Anonymised healthcare data for the whole population means that clinical trials can access 3 million people. Having a life science sector of significant value to the Welsh economy gives us a political voice and the support of our ministers, who work closely with us to enable growth. We have a dedicated Welsh Government life science sector team to help companies and academia develop.
For both Wales’ indigenous companies and those looking to set up or relocate to Wales, support accessing finance, clinical expertise and international trade markets is crucial.
Accessing finance:
Bio International Convention, Boston, USA, 18-21 June 2012 China International Medical Equipment Fair, China, 2-4 September 2012 Advamed, Boston, USA, 1-3 October 2012
Companies based in Wales can benefit from the UK Government’s offerings, such as tax breaks and the patent box initiatives, whilst also benefitting from support unique to Wales.
AusBio, Melbourne, Australia, 30 October – 2 November 2012
For instance, the Welsh Government’s £100 million Life Sciences Fund is soon to be operational. This commercial fund, delivered through independently assigned managers, should inspire Welsh companies and those looking to relocate to Wales to develop robust proposals. Similar to any commercial fund, only exceptional ideas demonstrating tangible return on investment will be successful. Initiatives such as these promote a competitive environment, key to survival and growth.
Next year, the Welsh life sciences community will also be represented at:
The Welsh Government currently invests over £40 million in National Health Service R&D every year. The Welsh Life Sciences Fund will complement this investment, helping keep commercial outcomes from funded R&D in Wales.
Medica, Dusseldorf, Germany, 14-17 November 2012
Arab Health, Dubai, UAE, 28-31 January 2013 China International Medical Equipment Fair, Shenzhen, China, 17-20 April 2013
Connectivity Accessing clinical expertise: The resounding message from Wales’ contract research and testing community is that Wales is open for business. With subsector strengths in wound healing, diagnostics and assistive technology and eHealth, this is the place to carry out your research and development (R&D). Companies understand that Wales not only offers a cost effective manufacturing base but houses the necessary skills, expertise and infrastructure to provide an excellent environment for research. Feedback from Advamed – the largest American health technology trade association – on the perception of Europe as a destination for R&D holds potential consequences for Wales. American companies’ experience infers that health technology trials and evaluations in Europe can be done at half the time and cost of those in America. The design and patient recruitment for studies is viewed as simpler, with a free healthcare system that naturally encourages greater patient engagement. This knowledge provides Wales with an opportunity to attract clinical trials/ evaluations and commercialisation of medical technologies from outside Europe due to its unique size, networks and devolved NHS. The following section takes a brief look at just a few of the organisations that make Wales such an attractive location to carry out R&D:
Health Research Wales The National Institute for Social Care and Health Research (NISCHR) is the Welsh Government body that develops strategy and policy for research in the NHS and social care in Wales. The NISCHR Academic Health Science Collaboration (AHSC) is part of the research infrastructure for Wales funded by NISCHR. It facilitates collaboration between NHS organisations, higher education institutions and the industry sector in Wales to support research excellence and create world-leading improvements in healthcare.
NISCHR AHSC hosts Health Research Wales - a vehicle to facilitate the effective set-up, management and delivery of commercial clinical research in Wales. It supports the development of productive relationships between commercial companies, universities and the NHS, demonstrating that Wales is a great place to do research. Health Research Wales will: Provide a single communication route for industry Offer support and guidance through the research process Signpost additional support and funding opportunities Facilitate quick and easy site identification including support in feasibility assessment
Cardiff University - Anaesthesia Innovation Anaesthesia Innovation (AI) is a new venture intended to pool together the academic expertise of Anaesthetics, Intensive Care and Pain Medicine with colleagues from the NHS, industry, other schools in Cardiff University and throughout the world. The aim is to forge links for developing successful novel, innovative products and provide a hub for clinically-relevant research. They have been involved in several innovative research projects, for instance the Hall Lock device - a collaborative project with Flexicare Medical Ltd, which has been CE marked, is in clinical trial, and in the process of being marketed. Another is the South West and South Wales Critical Care Alliance which was formed in 2011 to address a major unmet need in the treatment of sepsis, a major global killer with an estimated 18 million cases per annum. AI is split into 6 integrated sections: medical device testing; product development; user assessments; applying for charity and government funds; consultancy and simulation. Open for business, the institute welcomes contact from those wishing to initiate studies.
5
6
WALES medica special
WALES medica special Cardiff University – Wound Healing Research Unit (WHRU) WHRU has three core activities: specialist clinical services, research, and education and training. Research includes conducting clinical trials; biological research (with a particular emphasis on microbiology and material science); physical measurement (the interface of medicine and engineering/electronics); and health services research (including health economics). The target markets include health professionals working with non-healing acute or chronic wounds and health care companies involved in specialist wound care.
Swansea University – Health Information Research Unit (HIRU) The Health Information Research Unit (HIRU) based at Swansea University established the Secure Anonymised Information Linkage (SAIL) project to link together the widest possible range of anonymised person-based data using the School of Medicine’s IBM supercomputer (Blue C). Having successfully accomplished this, HIRU is expanding the databank, both in types of dataset and in geographical coverage. This provides a valuable resource for health-related research and service development, whilst complying with the requirements of data protection legislation and confidentiality guidelines.
Swansea University – eHealth Industries Innovation Centre (ehi2) ehi² provides businesses with opportunities to test, adapt, improve and evaluate eHealth products and services in a safe and reliable environment. It advises and assists companies and can facilitate access to clinicians, academic experts, NHS organisations, and national NHS IT and ICT programmes. It works with the NHS and other health systems to identify needs for new products and services.
Adding to their eHealth capabilities, in August 2012 Swansea University was made one of four eHealth research Centres of Excellence and is testament to the investment from Welsh Government and the European Union in the skills and expertise at the Institute of Life Science, College of Medicine, Swansea University.
Swansea University – Institute of Life Science (ILS) Phase 2 of the Institute of Life Sciences at Swansea University is a £30 million facility providing state-of-the-art clinical research facilities and an imaging suite. This institute provides an environment to undertake world-class and internationally recognised research, proving an excellent location for highgrowth companies in the sector. These organisations, and others, are supported and represented through several working groups created to influence the Welsh Government’s policies and agendas for Welsh healthcare. Missions such as Medica are vital to this sector, providing a platform to build Wales’ reputation as a desirable place to do business, innovate and carry out specialist research.
Penn Pharma Penn is a leading provider of integrated pharmaceutical development, clinical trial supply and custom manufacturing services to the international healthcare industry. Offering specialised contract manufacture and Qualified Person release services, Penn are an excellent contract research organisation supplier. Penn manufactures to GMP (Good Manufacturing Practice) and is licensed by the UK’s MHRA (Medicines and Healthcare products Regulatory Agency) and is FDA (US Food and Drug Administration) inspected.
Surgical Materials Testing Laboratory (SMTL) The Surgical Materials Testing Laboratory, part of the Welsh NHS, provides a range of testing and technical
services to the NHS and the medical device industry worldwide, including: l Physical and biological testing
of disposable medical devices to national and international standards l Dressings testing and bandage
testing l Biological and microbiological testing l Hosiery and glove testing l Environmental monitoring of
cleanrooms (to ISO 14644-1 and GMP) l Surgical instrument evaluations
(single use and reusable) l Test method development, R&D and
incident investigation
Cedar Cedar is an NHS evaluation centre, providing information and recommendations on emerging health technologies, medical devices, diagnostic testing, healthcare interventions and NHS service configuration. Cedar is part of the Cardiff and Vale University Health Board (UHB) as well as being one of four external assessment centres for National Institute for Health and Clinical Excellence (NICE), working on their Evaluation Pathway for Medical Technologies. In addition to their work for NICE, Cedar is able to undertake bespoke work for organisations. Recent examples include work for the Medicines and Healthcare Products Regulatory Agency (MHRA), Department of Obstetrics and Gynaecology at Cardiff and Vale UHB and the medical device industry.
7
Save the date
19th & 20th March 2013 Conference & Exhibition Cardiƨ Wales UK
Register your interest:
lifesciences@wales.gsi.gov.uk www.biowalesevent.com WG16863 / G/MH/4539 / 1012 / Š Crown copyright 2012
IP for the Life Sciences • Patents
• Trade Marks
Offices in Cardiff and Cheltenham Tel: +44 (0) 2920 786535 Email: email@wynne-jones.com Web: www.wynne-jones.com
Why Wales Works...
for Life Sciences
WALES medica special
Strategic location just two hours from London, with rail, air and sea transportation links to all major U.K. and continental markets. Specialist areas in life sciences including medical technology, diagnostics, regenerative medicine, contract research organisations, and eHealth. The highest level of financial support and grants offered in the UK, with quick decisions and approvals. £100 million Life Sciences Investment Fund to support and develop the life sciences sector in Wales. An independent and devolved National Health Service (NHS) system committed to supporting innovative technologies and therapies to reduce costs and improve patient outcomes. Quality and competitively-priced commercial and industrial property, some 40% lower than London rates.1 Renowned university system with research focused on industrial collaboration and more than 12,000 graduates across life sciences disciplines each year.2 Massive broadband availability, with a commitment to roll out Next Generation Broadband across Wales by 2015. Ready-built supply chains and support infrastructure in place to serve a growing cluster of life sciences companies. Exceptional quality of life, with beautiful beaches, national parks and more than 200 golf courses.
If you’re looking for the right place for growth and opportunity in the life sciences, look no further than Wales. Why? Because Wales, UK is home to more than 300 life sciences companies that employ some 15,000 people. The sector comprises a dynamic mix of companies, from local innovators to global players. Organisations large and small, in all stages of development, have found Wales to be a stellar combination of access to talent; a renowned university system; unparalleled lifestyle; and easy access to European gateways.
Finance With the highest level of business finance support and grants in the UK, life sciences companies that choose Wales also have access to the recently announced Life Sciences Investment Fund, a dedicated equity fund worth up to £100 million to support the development of life sciences businesses. As part of the UK, life sciences companies based in Wales are eligible for the UK Patent Box, an initiative that provides significant tax breaks for companies that commercialise patents and develop innovative patented products in the UK. Our dedicated technology and innovation team offers support and advice to life sciences companies of all sizes on new product and process development, intellectual property, technology networking, NHS contract procurement, and access to relevant academic expertise in Wales and beyond. The team can also facilitate access to R&D financial programs and assist with sourcing funding from other UK and European R&D initiatives.
Access to Markets Located just two hours west of London, Wales offers excellent rail, sea and air transportation links to the UK, European and continental marketplace, with an established infrastructure and supply chain already in place to serve a growing cluster of life sciences companies. The 1] Jones Lang LaSalle South Wales Report 2012 2] Touchdowncardiff.com/lifesciences/
Welsh Government has committed to rolling out a Next Generation Broadband Network that aims to ensure that all residential and business premises have access to 30mb high speed broadband by 2015 —well ahead of European targets. More than half of these locations will have access to a 100Mbps service. With an exceptional variety of business property—from starter industrial units and R&D incubators, to serviced offices and international headquarters, to urban renewal projects—property is highly cost competitive, with Cardiff office space some 40% less than London.1
Skills The University of Wales’ renowned higher education system boasts eight key universities and a total student population of more than 146,000, with more than
12,000 graduates in life sciences.2 Worldclass academic research facilities push the boundaries of research in stem cells, cellular analysis, body imaging, wound care, in vitro diagnostics, medical devices and more. Cardiff University is home to Sir Martin Evans, winner of the Lasker Prize, and considered by many to be the “father” of stem cell research. Swansea University’s Institute for Life Sciences I and II capitalises on growing research expertise and interactions with major international companies, to foster a life sciences cluster that has increased from zero to more than 50 companies surrounding the University since 2007. Wales has a number of strong business support platforms tied to academia that specialise in supporting R&D to foster innovative practices and production in the life sciences sector. Furthermore, Academic Expertise for Business (A4B) is a six-year, £70 million program of support established by the Welsh Government to encourage the transfer of knowledge and skills between academic institutions and business.
Collaboration Fostering innovation, collaboration and partnerships in life sciences is a key priority for Wales. Sir Chris Evans, a noted Welsh biotech entrepreneur and founder of Merlin Biosciences, leads the Life Sciences Sector Panel for Wales, which is empowered to serve as a bridge between the public and private sectors, and to help companies grow and succeed.
“Wales boasts some of the most outstanding scientific talent in this area and the challenge is now for entrepreneurs and businesses in the life sciences sector to grab the many opportunities out there.” Sir Chris Evans, Chair, Life Sciences Sector Panel
Key players Alere Aptuit BBI Biomet BioMonde ConvaTec Frontier Medical Group GE Healthcare Huntleigh Norgine OrthoClinical Diagnostics Penn Pharmaceuticals Siemens Healthcare Diagnostics
For further information please contact: Welsh Government Life Sciences Team Business, Enterprise, Technology and Science (BETS).
Tel: 03000 603000 or email: lifesciences@wales.gsi.gov.uk
10
WALES medica special
Welsh Government - Life Science Sector
Attending: Catrin Lloyd, Business Development Manager
Welsh Government Llys y Ddraig Penllergaer Business Park Swansea SA4 9NX UK Tel: Contact No. +44 (0)3000 603 000 Email: business@wales.gsi.gov.uk Web: www.wales.com/business
The Welsh Government has a fresh vision for life sciences. It is committed to creating the best possible environment for life sciences innovation and business growth with the creation of a strong ecosystem and a central hub resource, connecting academics, clinicians, entrepreneurs and investors in Wales and linking them to international partners. Wales is also one of the few areas in the UK able to offer significant grant funding to support the establishment and expansion of companies in Wales, in addition to access to equity funding through Finance Wales, a subsidiary of the Welsh Government, and the newly created £100m Welsh Life Sciences Investment Fund. Having our own NHS Wales means that clinical trials can access 3 million people through only 7 Health Boards, with a single coordinated permissions process. Wales has significant areas of excellence in life sciences and a formidable network of support. Wales has particular strength in the areas of in-vitro diagnostics, with the largest cluster of manufacturing facilities in the UK based in Wales, wound healing and in eHealth. The Medical Research Council’s eHealth Centre of Excellence, eHealth Industries Innovation Centre (ehi2), NHS Wales’ Informatics Service, and the Centre for Health Information Research and Evaluation (CHIRAL) at Swansea, provide a rich environment in which eHealth companies can develop and refine their products in a physical environment representing the entire patient journey through the healthcare system. Live integration with all NHS software systems runs on secure servers accessing over 2 billion patient episodes through the longitudinal SAIL dataset (Secure Anonymised Information Linkage). As a location, Wales provides a dynamic, innovative culture for pursuing discoveries and new product developments along with a strong cluster of clinical trial facilities able to undertake product testing.
80 Mochdre Enterprise Park Newtown Powys SY16 4LE UK Tel: +44 (0)1686 611333 Email: sales@cellpath.co.uk Web: www.cellpath.co.uk
CellPath is a specialist and innovative manufacturer of cellular pathology consumables for histology and cytology laboratories within the healthcare and pharmaceutical market. The range of products covers all aspects of the modern laboratory, with products for sample transport, analysis and storage including processing reagents, fixatives, stains and mountants. All available products are CE IVD compliant where appropriate and our manufacturing site is ISO 9001:2008 and ISO 13485:2003 accredited. Our dedicated team include laboratory trained staff with a wealth of experience in cellular pathology. CellPath has an active research programme with continuing development of a range of new and exciting products for the end user. CellPath is aiming to recruit new international distributors to sell the full product range, meet existing distributors and suppliers and offer sales support to promote CellPath products.
Chris Davies, Business Development Manager Arron Munkley, Business Development Executive
EXHIBITORS
Elizabeth McCargo, Business Development Executive
CellPath
Attending: Philip Webber, Managing Director Paul Webber, Managing Director Mark Wilson, Export Sales Manager Lewis Duckmanton, Sales Account Manager Andrew Callander, Overseas Sales Coordinator
11 WA L E S PAV I L I O N D I R E CTO R Y E X H I B I TO R S
DTR Medical
Attending: Andrew Davidson, Managing Director Neil McDermott, Business Manager Ed Casey, Export Coordinator (Customer Services) Tim Christopher, Marketing
17 Clarion Court, Clarion Close, Enterprise Park. Swansea SA6 8RF UK Tel: +44 (0)1792 797 910 Fax: +44 (0)1792 797 955 Email: info@dtrmedical.com Web: www.dtrmedical.com Twitter: @dtrmedical
The DTR Medical range includes many new sterile single-use surgical instruments for specialities including ENT, neurosurgery, vascular and general surgery, gynaecological procedures and orthopaedic surgery. In addition, the company supplies a range of products for sterile services including sterile pre-cut silicone tubing. DTR Medical continually expands its product range to meet new market demands and many of these new developments will be showcased on their stand at Medica. DTR Medical has several objectives for Medica 2012: to recruit new international distributors to sell their new product range worldwide; meet existing distributors and suppliers; and look for new products, whilst showcasing latest product developments.
Exopack® Advanced Coatings Ash Road North Wrexham Industrial Estate Wrexham LL13 9UF Tel: +44 (0)1978660241 Email: geninf@exopack.com Web: www.exopackadvancedcoatings.com
Exopack® Advanced Coatings produces the inspire® range of films and foams for manufacturers in the wound care, ostomy and medical device sectors. Films, foams and adhesives are combined in a variety of ways to create novel features or brand identity. Several composites are available as part of the standard inspire® portfolio with an added printing facility, if required. The new inspire® polyurethane foam range offers unparallelled breathability, conformability, elasticity, softness and protection. They are available in a range of colours, including white, and are ideally suited as a backing or support layer for professional wound dressings and plasters to be sold into the consumer market. Carbon-containing films that can be modified with silver or silver/ silver chloride are also part of the inspire® portfolio suitable for electrode applications including ECG, TNS, biosensors and cosmetic applications. Exopack® Advanced Coatings also offers papers, films and specialty substrates for press supplies, electronics and optical technologies.
Whiteleys, Little Treffgarne, Haverfordwest SA62 5DY Tel: +44 (0)1437 741700 Fax: +44 (0)1437 741781 Email: admin@friouk.com Web: www.friouk.com
FRIO UK Ltd is the inventor and manufacturer of the innovative patented and trademarked FRÍO range of medical cooling products with manufacturing facilities in UK and overseas. The FRÍO® travel wallet offers diabetics around the world the ultimate stylish accessory for the safe and convenient storage or transportation of insulin. The FRÍO® is an evaporative cooling unit purposefully designed to keep in-use insulin and temperature sensitive medications cool and safe. FRÍO’s sports and leisure range of cooling products includes head, neck, wrist and ankle bands, drinks coolers and Migra head soother for pain relief. Awards: Design Council’s Millennium Products Award for creative and innovative products for the new Millennium; DTI’s National Language for Export Awards – Regional Merit Award. FRÍO® cooling products are currently distributed in 57 countries. Principle markets are USA, Europe and MENA area. Our focus is on expanding our export market and meeting potential new distributors
Attending: Kevin Schofield, Medical Market Manager Sharon Jones, Key Account Manager - Medical Fraser Kinnaird, Sales & Marketing Director Joanne Parrott, Marketing Communications & Administration Manager
FRIO UK
Attending: Chris Wolsey, Managing Director Paul Dale, General Manager
12
WALES medica special
GX Group GX Group The Mayfield Usk, Monmouthshire NP15 1SY UK Tel: +44(0)1291 673437 Claire Banks’ mobile: 07790315250 Email: claire.banks@gxgroup.com Web: www.gxgroup.com
Attending: Claire Banks, Business Development Manager Seb Weatherall, Industrial Designer
GX Design Engineers, part of the GX Group, is one of the UK’s leading medical and scientific technology and innovation companies, offering a multidisciplinary and holistic approach to new product design engineering and development. Specialising in electronics, industrial design, mechanical engineering, rapid prototyping, software, optronics, microfluidics, value engineering and regulatory support, GX’s talented design teams are experienced in handling projects from conception through to production and commercial reality. Their successful and profitable diagnostic devices, surgical and scientific instrumentation and hospital and healthcare equipment have included: l Industry defining urine analysis reader - on sale worldwide l Market-leading laparoscopic trainer - used in training hospitals throughout the UK l ‘Model Gut’ - major diagnostic advance for the pharmaceutical and medical industry l Award-winning, commercially successful X-ray analysis technology Clients include Bayer, Pall, BOC Linde Group, Accora, AssayMetrics, and Olympus - Gyrus ACMI. The GX Group also comprises GX Systems, GX Environmental and GX Tracking.
Pelican Feminine Healthcare Pelican Feminine Healthcare Ltd Cardiff Business Park Cardiff CF14 5WF UK Tel: +44 (0)2920 747000 Fax: +44 (0)2920 747001 Web: www.pelicanfh.co.uk
Attending: James Eagle, Export Sales Manager Simone Steventon, Business Development Manager
Pelican Feminine Healthcare manufactures a range of single-use instruments, specialising in gynaecology products, including the market leading PELIspec vaginal speculum. Pelican’s commitment to the feminine healthcare market led to the recent acquisition of Clinical Innovations Europe Ltd. The Clinical Innovations range of single use gynaecological and obstetrics products, including the market leading KiwiTM Vacuum Assisted Delivery System, complement Pelican’s existing product offerings perfectly. With an active research and development programme and a positive input from specialist clinicians and other professional customers, Pelican Feminine Healthcare remains committed to bringing innovative, clinically and cost effective products to the feminine healthcare market. Pelican Feminine Healthcare is passionate about delivering high quality medical products and world class levels of customer service. They are looking to meet new European distributors, particularly Eastern Europe, for their products as well as to meet inventors, suppliers or manufacturers of innovative obstetric and gynaecological products.
13 WA L E S PAV I L I O N D I R E CTO R Y E X H I B I TO R S
The Magstim Company
Attending: Robin Davies, Managing Director Chris Hovey, Business Manager - IOM Kirsty Martin, Business Manager - Neuroscience
The Magstim Company Ltd Spring Gardens Whitland Carmarthenshire SA34 0HR Tel: +44 (0)1994 240798 Fax: +44 (0)1994 240061 Email: john.scandone@magstim.com Web: www.magstim.com  Â
Magstim provides the means for neuroscientists to work with the human brain in awake subjects by manufacturing and supplying state-of-the-art clinical and research instruments. Magstim and Neurosign products cover the fields of Neurology, Neurophysiology, Psychiatry and Cognitive Neuroscience as well as ENT, Orthopaedic and Neurosurgery. Magstim maintains a strong commitment to R&D and product improvement. Collaborating with researchers in British and European major centres of expertise (as well as those in North America and Japan) ensures that Magstim remains informed about clinical and medical advances, enabling the company to develop products at the forefront of technology.
Tredegar Business Park, Tredegar, Blaenau Gwent, NP22 3EL, UK Tel: +44 (0)2921 25 1955 Email: cmg@tonuseurope.com Web: www.tonuseurope.com
Tonus Europe Limited has invested heavily to expand its activities and product range globally. Its UK office is part of the Tonus Healthcare Group whose headquarters are in the Latvian city of Liepaja on the Baltic coast. Formed in 1995 with new offices in the UK, Tonus are seeking distributors and partners for its existing and future product ranges. Tonus manufactures a wide variety of elastic medical products, from bandages to complex corsetry, and a range of maternity lingerie. Tonus has a market leading range of Lymphoedema compression stockings, compression garments for postoperative surgery, posture compressive garments and a range of sports compression performance wear, whose benefits have been proven through medically inspired construction, working muscles to drain toxins and reduce muscle fatigue. Collaborating with universities and manufacturers in the UK enables us to offer a market opportunity for distributors globally, please contact us for more information.
Tonus Europe
Attending:
Chris Groves, Managing Director Dana Preiss, Sales & Marketing Director Gatis Sturis Export Manager Louise MacCormac Commercial Manager
WALES medica special
VISITORS
14
Benchmark Technologies Unit 307 Springvale Industrial Estate Cwmbran NP44 5BR UK Tel: +44 (0)1633 877569 Email: info@dermashield.co.uk Web: www.dermashield.co.uk
Attending: Peter Friswell, Managing Director
Are you seeking to collaborate with an organisation to market high quality, good profit margin products through both clinicians and over the counter? Benchmark Technologies are specialist manufacturers of high quality skincare preparations that are marketed at premium prices. One of our products is an effective treatment for dermatitis and other common skincare conditions. It has produced very favourable clinical trials and is available both as OTC and on prescription. We are actively seeking an organisation with complimentary resources to work with us to expand and accelerate this product’s current market penetration and fulfil its phenomenal global potential. We undertake the full range of new product development activity needed to take a device from its conception through to successful market launch and beyond. These range from full engineering analysis systems through to a world leading approach and specialised facilities in rapid human factors and usability assessment.
Calon Cardio-Technology Institute of Life Science 2 Swansea University Swansea SA2 8PP UK Tel: +44 (0)1792602861 Email: kevin@caloncardio.com Web: www.caloncardio.com
Attending: Kevin Fernquest, Managing Director
Calon Cardio-Technology Ltd (Calon) is developing a new generation of implantable micro-pump for the treatment of heart failure more commonly known as Ventricular Assist Devices (VADs). Current pumps have clinically proven that heart assist pumps are a safe and effective therapy. However, these devices have so far failed to exploit their huge market potential for two reasons: current products are too large requiring highly invasive surgery and they are expensive circ 115k USD. Calon’s technology aims to solve both problems as VADs are increasingly recognised as a viable long term treatment option. Their use has become routine in the USA and some EU markets to “bridge” transplant patients until a donor heart becomes available plus they are also gaining increased acceptance as long term alternatives to transplantation. Calon have assembled a team of world class suppliers and collaborators to take their vision to market.
Cardiff Council Economic Development City Development, City Hall Cathays Park, Cardiff, CF10 3ND Tel: +44 (0)29 2087 1411 Email: businessadvice@cardiff.gov.uk Web: www.cardiff.gov.uk
Attending: Neil Hanratty, Chief Officer for City Development Ken Poole, Head of Economic Development Gareth Newell, Economic Development Manager Alicja Slawik, Business Development Officer Gemma Brown (nee Jones), Marketing Officer
Cardiff is a vibrant European capital city with an international reputation as a high quality and competitive business location less than two hours from London and Heathrow Airport. Cardiff and its city region has one of the fastest growing economies in the UK supported by a flourishing life sciences sector of over 200 companies, including: GE Healthcare, who are on the verge of opening their new pioneering Cell Science Laboratories; Gyrus Medical; Genesis Biosciences; Norgine; Huntleigh Diagnostics; and Penn Pharmaceuticals Ltd. Life sciences has been identified as one of the key sectors of both Cardiff and Wales’ economy. There are over 5000 people employed in the sector in the city region, and circa half of these in the city itself, giving Cardiff a higher per capita employment in the sector than any other UK city. Cardiff’s success in the life sciences sector is built on worldleading advanced infrastructure and an extremely competitive cost base. By locating in Cardiff, companies within the sector can enjoy various other advantages, such as: access to funding, including the Welsh Government’s £100m Life Sciences Wales Investment Fund and Cardiff Council’s Capital Cardiff Fund; a bespoke high-quality property portfolio with flexible leasing terms; and a dedicated Economic Development team to support all aspects of setting up a business in the city.
15 WA L E S PAV I L I O N D I R E CTO R Y V I S I TO R S
Creative Packaging 39 Millers Avenue, Brynmenyn Industrial Estate, Bridgend CF32 9TD Email: lyndon@creative-packaging.co.uk Tel: +44 (0)1656 720444 Mob: +44 (0)7900214089 Web: www.creative-packaging.co.uk Attending: Lyndon Powell, Managing Director
Creative Packaging offers clients within the medical industry a complete design and manufacture service for their packaging requirements. Their innovative approach to packaging projects has enabled them to offer solutions within the pharmaceutical, technology and medical device sectors. Skills include graphic design and cardboard engineering, complimented by a manufacturing facility that offers trial runs to high volume production. During the past fourteen years, the company has designed and manufactured packaging for companies throughout the UK and Europe. A recent move to larger premises and investment in increased manufacturing capacity has enabled them to further enhance their services.
Direct Healthcare Services 8-10 Withey Court Western Industrial Estate Caerphilly CF83 1BF Tel: +44 (0)845 459 9831 Mobile: +44 (0)7837 766044 Email: graham.ewart@direct-healthcare.org.uk Web: www.directhealthcareservices.co.uk Â
Multi award-winning Direct Healthcare Services Ltd are the fastest growing UK manufacturer of pressure area care products in the UK, with a fully integrated design and manufacturing facility based in Caerphilly, South Wales. Focused on quality, innovation and best value solutions Direct Healthcare Services are accredited to ISO 9001 and ISO 14001. With increasing focus on the rising cost of treating pressure ulcers Intelligent Pressure Care Management from Direct Healthcare Services is an innovative new solution in the prevention and treatment of pressure ulcers. Utilising the award-winning Dyna-Form patient support systems, the development of Intelligent Pressure Care Management has been guided by the recognition that within pressure ulcer prevention protocol, intervention at the earliest possible opportunity along with appropriate selection of support surface are key factors now more than ever. With significant experience in the provision of clinically proven, value for money solutions, you can be sure that our combination of innovative pressure care technologies, designed in partnership with leading clinical and healthcare establishments, deliver solutions that meet the needs of most patient groups, including our increasingly elderly population.
E2L Products Limited 19 White Swan Court Priory Street Monmouth NP25 3NY Tel: +44 (0)1600714856 Email: info@e2l.uk.com Web: www.e2l.uk.com
Consultant engineering product designers with electronic, mechanical and industrial design skills, specialising in joint collaborations with organisations and individuals within the medical sector. An ISO9001:2008 accredited design process and a flexible approach to project financing, E2L have a track record of converting clinical needs into market ready products. Focussed on design simplicity, alternative thinking and functional necessity. A strong history of product development in collaboration with NHS. R&D resource for new products/inventions requiring electronic and mechanical engineering inputs and ongoing development through to manufacture. Expertise with portable systems, battery operated, low power systems, wireless communications. Resulting products are all sold through third party agents, joint venture partners, or under licence arrangements. Actively involved in various health areas including AAC, anaesthesia, urodynamics, orthopaedics, burns, learning difficulties and paramedics.
Attending: Graham Ewart, Managing Director
E2L Products
Attending: Lyndon Owen, Managing Director
16
WALES medica special
Frontier Medical Group Newbridge Road Industrial Estate Blackwood NP12 2YN +44 (0)1495 235800 www.frontier-group.co.uk info@frontier-group.co.uk
Frontier Medical Group manufactures and markets a range of medical products in three broad business streams: l
Sharpsafe is Europe’s leading brand of plastic sharps disposal containers
l
Repose is a range of inflatable polyurethane pressure redistribution devices for the prevention and treatment of pressure ulcers, manufactured under license from the NHS
Exchange is the brand under which products are made available to organisations for harm reduction purposes amongst the intravenous drug-using community Frontier is based at two factories in Blackwood with facilities for plastic injection moulding and welding. The core market in the UK is the NHS although approximately 50% of production is exported, mostly to the EC.
l
Nick Davis Group Managing Director
Health Research Wales Health Research Wales 2nd Floor, 12 Cathedral Road Cardiff, CF11 9LJ, UK Tel: +44 (0)2920 196818 Email: contact@healthresearchwales. com Web: www.healthresearchwales.com
Attending: David Powell, MSc, Health Research Wales Bev Luchmun, NISCHR Industry Lead Carys Thomas, Head of NHS R&D Strategy & Funding – NISCHR
The National Institute for Social Care and Health Research (NISCHR) is the Welsh Government body that develops strategy and policy for research in the NHS and social care in Wales. The NISCHR Academic Health Science Collaboration (AHSC) is part of the research infrastructure for Wales funded by NISCHR and facilitates collaboration between NHS organisations, higher education institutions and the industry sector in Wales to support research excellence and create world-leading improvements in healthcare. NISCHR AHSC hosts Health Research Wales, which is a signposting and facilitation service for commercial R&D. The Health Research Wales service maintains a commercial research register of interests/ specialisms and research resources available in Wales. Through our industry team, Health Research Wales facilitates the set up and delivery of commercial research, as well as the development of new relationships between commercial companies and NHS Wales. In addition to its industry remit, NISCHR AHSC develops capacity in the NHS to support high quality research by running responsive funding schemes. NISCHR AHSC also hosts both the Permissions Co-ordinating Unit (PCU); which co-ordinates the process for gaining research permission from NHS organisations across Wales; as well as the Research Ethics Service (RES) which protects the rights, safety, dignity and well-being of research participants; and facilitates/ promotes ethical research that is of potential benefit to participants, science and society.
17 WA L E S PAV I L I O N D I R E CTO R Y V I S I TO R S
Huntleigh Tel: +44 (0)29 20485885 Email: sales@huntleigh-diagnostics.co.uk Web: www.huntleigh-diagnostics.com Hall 9; Stand A32
Attending:
Greg Baily, Technical Director
Huntleigh, a member of the Getinge group of companies, is a leading global provider of innovative and high quality medical equipment for healthcare professionals. The Diagnostic Products Division can proudly boast world leading brands such as Sonicaid, Dopplex and Smartsigns, covering healthcare requirements in obstetrics, vascular assessment and patient monitoring. The ISO 13485 accredited site at Cardiff is the largest manufacturer of foetal monitors in the UK and its position has been strengthened with the introduction of portable foetal monitors; monitors with telemedicine capabilities and electronic viewing; and archiving systems. The Smartsigns brand of patient monitors compliment the obstetric and vascular business enabling Huntleigh to offer complete solutions to medical professionals world-wide. The site also offers expertise in electronic components and software that support product lines throughout the entire group.
Innoture
Attending: Chris Williams, Director R&D Ben Fisher, Director Operational Jon White, Manufacturing Ryan Bamsey, Project Management
Regus House, Falcon Drive Cardiff Bay, Cardiff CF10 4RU Alternate: Research Centre - ILS 2 – Swansea University, Swansea. Tel: +44 (0)2920 504104 Chris Williams’ mobile 07989763936 Email: cwilliams@innoture.com Web: www.innoture.com
Innoture has successfully patented its unique micro needle technology on a world- wide basis. Our production and development techniques are applied in a large range of modalities spanning medical and clinical applications, diagnostic testing, drug delivery and cosmetics. The extremely cost effective process capabilities, linked to our extensive patents, enable Innoture to develop cutting edge solutions rapidly and effectively. Current research projects range from diabetes administration and testing programmes, biological testing, cosmetic applications and the extension of our conductive systems
Plas Eirias Business Centre Colwyn Bay, LL29 8BF Tel: +44 (0)1492 510 329/ 0781 088 0301 Email: j.rees@jrbiomedical.com Web: www.jrbiomedical.com
JRBiomedical assists organisations both large and small with the development, launch and marketing of innovative healthcare products for the consumer and professional markets throughout the UK. Established in 2005, our clients have included diagnostics manufacturers, the NHS, high street retailers and pharmacy chains. We also develop our own IP and products. We currently have two licensing opportunities for companies that wish to extend their IP portfolio, consisting of patent applications in the fields of in-vitro diagnostic technology and malaria vaccines. The main purpose of our visit to Medica this year is to identify companies with innovative medical devices and in vitro diagnostics, especially in the self testing sector, who are looking to outsource the launch, marketing, distribution or customer support in the UK.
JRBiomedical
Attending: John Rees, Managing Director
18
WALES medica special
Kodit Database Evolution House, First Floor Suite Three, Lakeside Business Village, St David’s Park, CH5 3XP Phone: +44 (0)845 3707706 Email: info@kodit.com Web: www.kodit.com
Kodit design web-enabled mobile medical data collection and verification applications, which increase the efficiency of day-to-day medical procedures and provide clinicians with real time information crucial to the well being of their patients. Not limited to a Hospital setting, Kodit also provides systems for care home, residential care and care in the community. Our products have been designed with the input of clinicians, nursing staff and care workers to ensure that they are both easy to use and provide demonstrable benefit to their patients/residents. We have received significant support for our “CAREMagic Application store” from major mobile/communications device manufacturers, are about to launch the platfrom on the Fujitsu Cloud, and are also working with Swansea University in order to introduce our CAREMagic SDK (Systems Development Kit) to other Welsh SMEs. Overseas interest continues to be strong.
7 Schooner Way, Atlantic Wharf, Cardiff, CF10 4DZ Tel: +44(0)29 2047 3456 Email: debbie.laubach@mediwales.com Web: www.mediwales.com
MediWales has been active for over twenty years and is the representative body for the life sciences sector in Wales. MediWales is in regular communication with over 1700 named contacts, and currently has over 135 members. Supported by the Welsh Government, MediWales is owned by its members and led by directors drawn from senior industrialists and academics in Wales. MediWales generates a unique environment for networking, collaboration and communication between industry, higher education and health service members. This is delivered through an active schedule of seminar events and publications, supported by the MediWales website and maintained via constant communication with members and stakeholders. From this pivotal role, MediWales is able to represent both its members and the wider sector to governmental and international partners.
Western Avenue, Cardiff CF5 2YB UK Tel: Jarred: +44 (0)29 2041 7054 Ian: +44 (0)29 2041 7009 Email: jwevans@pdronline.co.uk iculverhouse@pdronline.co.uk Web: www.pdronline.co.uk
PDR is a leading medical device design and development centre encompassing research, usability and interaction design, product design and engineering, prototyping and low volume trial manufacture and verification. Located within one of Europe’s leading multidisciplinary product development centres, PDR has pioneered many new and novel approaches to effective, robust and reliable human-centred device development and appraisal. Over the last 18 years we have used these proven and highly experienced approaches to help large and small device and pharmaceutical companies from around the world to discover, design and develop compliant, safe and successful medical devices from deceptively simple rehabilitation aids through to complex diagnostic tools and drug delivery systems. With over 30 staff and comprehensive research, design, prototyping, analysis, usability and human factors facilities, device development at PDR is undertaken through a proven and robust design methodology to produce award winning, highly creative and reliable solutions.
Attending: Craig Story, Managing Director
MediWales
Attending: Debbie Laubach, Operations Manager Jess Fisher, Communications Manager
PDR
Attending: Jarred Evans, Commercial Director Ian Culverhouse, PhD, Product Interaction Designer
19 WA L E S PAV I L I O N D I R E CTO R Y V I S I TO R S
Rantmedia 22 Cathedral Road, Cardiff CF11 9LJ, UK Tel: +44 (0)29 2039 9189 Email: hello@rantmedia.com Website: www.rantmedia.com
Rantmedia - Maximising Mobile. Rantmedia is an established, specialist mobile agency with an emphasis on delivering creative, tailored and innovative app solutions and strategies. Our experience - developing mobile applications since 2008 - includes true 3D, augmented reality, interactive games, enterprise, brand and product applications. Our current client list includes numerous high-profile international brands. Our product - Blueline – is an app creation solution delivering customisable, high-quality sales/marketing/training mobile apps for medical products and services. Features include comprehensive navigation, transitions and sophisticated data visualisation, including 3D models with gesture-based manipulation. We operate at the forefront of mobile application development. See how we can work with you to deliver visually stunning eHealth solutions.
Sophia House, 28 Cathedral Road, Cardiff, CF11 9LJ Tel: +44 (0)29 2066 198 Email: info@rogue-resolutions.com Web: www.rogue-resolutions.com
Rogue Resolutions provides integrated equipment solutions and services within the neuromodulation, neuronavigation, brain imaging and neurofeedback sectors. In order to achieve this we have developed an extensive portfolio of products that are engineered to function in a seamless manner, maximising the potential of these complimentary devices and offering the customer a fully integrated solution to accomplish their research needs.
Attending: Anton Faulconbridge, Director
Rogue Resolutions
Attending: Andrew Thomas, Managing Director Dan Phillips
Spectrum Technologies Western Avenue, Bridgend CF31 3RT Tel: +44 (0)1656 655437 Email: sales@spectrumtech.com Web: www.spectrumtech.com Twitter: @Spectrum_Tech YouTube: SpecTech01 LinkedIn: Spectrum-Technologies-PLC Attending: Rachael Pugh, Marketing and Communications Manager Gareth Lewis, European Sales Engineer
Spectrum Technologies has been at the forefront of laser wire processing technology for over 20 years. The company was established in 1989 as a spin out from a British Aerospace research group and has subsequently commercialised UV laser wire marking technology for the aerospace industry. The company also designs and manufactures a range of SIENNA™ laser-based wire stripping and ablating products supplied to critical electronic device manufacturers operating in the consumer, defence and medical industries. Customers include TE Connectivity, Boston Scientific, Sorin Biomedica, GE and Siemens. Today the company employs 85 staff worldwide with sales and service offices in Texas, USA and Shanghai, China. All design and manufacturing is carried out at the company’s UK headquarters in Bridgend.
20
WALES medica special
Springdew Units 9-12 Woodlands Business Park Ystradgynlais Swansea SA9 1JW United Kingdom Tel: +44 (0)1639 849676 Fax: +44 (0)1639 845662 Email: paul.evans@springdew.co.uk Web: www.springdew.co.uk
Attending: Paul Evans, Joint Managing Director
Springdew Limited is a family-owned business located near Swansea in South Wales. We are very close to the UK motorway network and only 3 hours away from London Heathrow. We are a cost-effective Packaging Services Provider to the Pharmaceutical, Healthcare, Veterinary & Medical Device markets. We are flexible, responsive and operate to strict GMP standards. We hold an MHRA assembly license, as well as ISO 13485 and ISO 9001 accreditations. Our packaging services include carton/leaflet replacement, hand assembly, inspection, shelf-ready packing, carton-erection, security tagging, RF sealing, blister carding, flow-wrapping, clip-strip assembly, over-wrapping, counter-top units, free-standing retail display units & wholesale pallet displays. We also have in-house vacuum forming facilities. We offer full QP Release to Market. Our purpose-built warehouse is temperature-controlled. Receipts, reconciliation and returns are handled in accordance with agreed SOPs. Our packaging facilities are designed to optimize GMPcompliant workflow and our team of highly-qualified professionals ensures compliance with regulatory requirements.
Swansea University – Institute of Life Science Institute of Life Science Swansea University Singleton Park Swansea SA2 8PP Tel: +44 (0)1792 513705 Email: ilscommunications@swansea.ac.uk Web: www.swansea.ac.uk/ils/home
Attending: Sarah Jones, Marketing Administrator
Swansea University is home to a thriving cluster of innovative life science and healthcare ventures centred around the Institute of Life Science (ILS), Wales’ premier medical and healthcare research facility. The ILS is a £100 million venture focused on maximising competitive advantage for its clients by bringing together multidisciplinary research, the NHS, industry and business. The project is funded via Welsh Government, through the European Regional Development Fund. The ILS provides access to exceptional resources for its clients including clinical research and imaging facilities, the UK centre for Mass Spectrometry, commercial laboratory space, business suites, hot-desk facilities and access to partner initiatives such as the Centre for NanoHealth. The ILS houses over 300 research specialists from cancer to eHealth to medical devices and is actively seeking new research collaborations, business partners and entrepreneurs looking for a supportive base in Wales.
UK HealthGateway
UK
HealthGateway
Attending: Jon Wilks, Managing Director Roy Lilley, Chairman
23 Cae Rex Llanblethian Vale of Glamorgan CF71 7JS Tel: +44 (0)7900570172 Email: jon@ukhealthgateway.com Web: www.ukhealthgateway.com
UK Healthgateway is the specialist UK health market entry expert. We offer: l Distributor search l Regulatory certification (CE all grades) l Market research l Clinical product assessment & trials l Commercial planning l Clinical PR and product advocacy l Legal and financial planning Our network of expert associates are the best in the business and our clients benefit from an unrivalled contacts network and NHS process understanding. Whether your product is equipment, device, consumable or pharmaceutical, we will make your market entry successful.
21 WA L E S PAV I L I O N D I R E CTO R Y V I S I TO R S
UPG a Medplast Company Cwm Cynon Industrial Estate North Plateau Mountain Ash, RCT CF45 4ER Tel: +44 (0)1443 471200 Email: nparsons@upgintl.com Web: www.upgintl.com
Attending: Neil Parsons, Regional Sales Manager
UPG is a leading provider of highly engineered custom plastic processing solutions serving the global healthcare market.We apply materials expertise in thermoplastics and elstomers to develop processing solutions for medical components and devices. We are an innovative global provider of product development and manufacturing solutions, servicing the medical market with tooling design and construction, custom injection moulded plastic components, semifinished sub-assemblies to multifaceted fully finished final products. UPG manufactures components and assemblies for an array of medical markets and products - Class 1 and class 2 medical devices. This includes minimally invasive surgical devices; respiratory, anaesthesia and catheter devices; infusion, diagnostic instruments and devices; and patient monitoring systems. UPG’s global expertise and processes are tailored to meet the stringent demands for today’s healthcare products. A single source supplier, we mitigate risk and complexity in our customer’s supply chain. Because we function as an extension of our customers’ manufacturing operations, our customers are able to focus on what they do best as a manufacturer and marketer.
Williams Medical Supplies Craiglas House, Maerdy Industrial Estate, Rhymney, Gwent, NP22 5PY Tel: +44 (0)1685 846666 Email: sales@wms.co.uk Web: www.wms.co.uk
Attending: Michael Walters, Head of Vendor Management Mark Watkins, Vendor Manager
Established in 1986, we are the leading provider of medical supplies and services to the UK healthcare market. Over 8,500 GP surgeries trust us to supply their medical equipment, pharmaceuticals, everyday consumables and family planning products. We also provide a broad range of added-value services including test & calibration, cqc management and health & safety consultations. Our medical equipment testing and calibration service is uniquely endorsed by all the major medical equipment manufacturers. We are based in a purpose built, state-of-the art facility close to the historic Welsh village of Rhymney at the foot of the Brecon Beacons. We’re a small, close-knit team who pride ourselves on providing our customers with excellent, friendly, knowledgeable – and hassle-free – service.
22
WALES medica special
GX Group GX Design Engineers is one of the UK’s leading medical and scientific technology companies, experienced in turning client ideas into commercial successes which maintain and grow market share. They specialise in electronics, industrial design, mechanical engineering, rapid prototyping, software, optronics, microfluidics, value engineering and regulatory support.
Their diagnostic devices, surgical and scientific instrumentation, and hospital and healthcare equipment projects include: l Industry-defining urine analysis reader - on sale worldwide l Market-leading laparoscopic trainer - in training hospitals nationwide l Award-winning, commercially successful X-ray analysis technology
The Aber Instruments CLYA Brewery Instrument Yeast Monitor GX designed and built the pint-sized yeast monitor to achieve reduced production costs and help brewers improve beer consistency. The CLYA is recognised as the most accurate and reliable measuring instrument of live cell concentration using biotech technology, and is used by the larger brewing groups and microbreweries.
Haemair Artificial Lung/Mass Exchanger GX designed an artificial lung to assist individuals with severe respiratory problems. GX’s innovative process enables the assembly of gas permeable hollow fibre mats to follow the form of the human body. No other mass exchanger does this. At the same time, the design gives enhanced efficiency in the transfer of oxygen from air to blood.
The PBL Dynamic Gastric Model – ‘Model Gut’ GX optimised the prototype Model Gut - which mimics the processes of the human stomach incorporating stomach acids and enzymes. It allows
pharmaceutical and food industries to explore the impact of new medicines, drugs and foods for the first time with a truly dynamic in-vitro system.
GX Group The Mayfield, USK Monmouthshire NP15 1SY UK Tel: +44 (0)1291 673437 Web: www.gxgroup.com
23
DTR Medical DTR Medical – a leading sterile single-use surgical instrument manufacturer – is developing its business using advanced manufacturing techniques to enable high quality volume production.
product has the opportunity to enhance current procedures and aid the prevention of crosscontamination.
Keen to innovate, reduce Your sterile single-use solution, its carbon footprint, and encourage the use of singlewithout compromise
use surgical instruments, DTR Medical is using computer aided design (CAD) and advanced moulding techniques to reproduce products previously sourced from Asia. For instance, the increasingly popular Frazier suction handle is now produced locally, enabling DTR Medical to meet the high demand for the product.
The nylon-based trigger handle and the metal jaw are made from high quality materials, utilising the advice of surgeons to create a truly fit-for-purpose product. The shaft and inner rod - made from stainless steel - actuate the jaw, forming a rigid instrument with no movement or flexing, allowing the surgeon to attain a sharp and clean cut.
Our combination of high
product will be launched at a quality innovative The products cost effective price, considerably less
Integral to the company is the adherence to international quality standards. By using CAD and automated procedures, the margin of error has been significantly reduced, providing standardized high quality product every time.
than what healthcare providers could
and exceptional levels ofEast manufactured pay for a Far instrument.
service provide supreme Going beyond single use instrumentation, DTR Medical
clinical value. recently played a pivotal role
Linking the ability to innovate and use the latest lean manufacturing techniques, the company has worked with clinicians to develop a single-use Rotating Cervical Biopsy Punch. This product removes the risks of cross contamination for patients undergoing cervical cancer biopsies.
in developing the fasciaformtympanoplasty procedure with the creation of reusable Tympanoplasty Moulds to allow for eardrum graft moulding. Published in a recent article by the Mail on Sunday - “The F1 Eardrum” - the company worked alongside consultant ENT surgeons in the UK and Canada to help bring this innovative idea to life.
With approximately 260,000 annual cervical biopsies conducted in the UK and the increased HPV testing demands, DTR Medical’s new
Specialities served: General eneral and VVascular, ascular ENT/MaxFax, Gynaecological, Neurosurgical rosurgical
DTR Medical Ltd 17 Clarion Court Clarion Close Enterprise Park Swansea SA6 8RF UK Tel: +44 (0) 1792 797 910 Fax: +44 (0) 1792 797 955 E-mail: info@dtrmedical.com Web: www.dtrmedical.com Twitter: @dtrmedical
24
WALES medica special
E2L Products E2L are consulting design engineers, specialising in joint collaborations with organisations and individuals in the medical sector. With an ISO9001:2008 accredited design process and a flexible approach to project financing, E2L have a track record of converting clinical needs into market-ready products. One of their latest products, a dedicated Burns Hydration Calculator for determining fluid resuscitation, is to be launched at Medica 2012. Working in collaboration with a spinoff company from Abertawe Bro Morgannwg NHS Trust, the Welsh Centre for Burns, and Swansea University, E2L signed a licencing agreement to take the initial concept and develop a market ready product with full CE and MHRA compliancy. The clinical requirement for such a device comes from the error prone methods currently used, such as hand calculation, nomograms, or Apps, and their lack of accountability. Protocols such as ‘Parkland’ and ‘Muir & Barclay’ for defining hydration rates are well established but this new device has the ability to validate the user inputs, select the regime, and compensate for fluids already administered. Importantly,
the device issues a paper printout detailing the calculations, what the workings are, and requiring a doctor to sign them off. Having a paper trail provides a clear statement of what’s been done, and is clearly set out for a doctor to sign off, with a paper copy included in the patient’s notes. The design uses a touch screen with sound and pictures as the human interface, utilising error checking input routines to avoid any false data entry. Clinical evaluation work by D. Williams and J.Dingley, anaesthetists at the Dept. of Anaesthesiology and Intensive Care, Morriston Hospital, has confirmed that the electronic
device has both speed and accuracy improvements over conventional methods. This project took E2L only two months in its entirety, without external funding, to achieve a market ready product.
E2L Ltd 19 White Swan Court Monmouth NP25 3NY UK Tel: +44 (0) 1600 714856 Email: info@e2l.uk.com Web: www.e2l.uk.com
25
FRIO UK An international, Pembrokeshirebased company, FRIO UK Ltd’s founders Garnet and Althea Wolsey invented the FRÍO® cooling wallet and sports and leisure ranges in the mid 1990s. FRÍO® cooling products are manufactured on-site using renewable energy supplying 100% of the factory’s energy requirements. FRÍO® wallets are patented, trademark protected, and available in 57 countries. The concept of using evaporation techniques for cooling purposes was developed and a number of cooling products ensued. FRÍO® cooling bands were utilized by British athletes at the Olympic Games in Atlanta, 1996. Later, Ferrari’s F1 team used the technology for body wear as an aid to keeping drivers cool. More recently, Ospreys Rugby trialed a scull-cap, which is now used nationwide. Their flagship product, the FRÍO® Insulin Cooling Wallet, underwent stringent testing by the British Medical Devices Evaluation Unit during 19961997. Subsequently, it was submitted to the FDA (USA), scrutinized and passed for sale. FRÍO® cooling wallets receive support from diabetes associations worldwide as well as the International Glaucoma Association and it’s widely recommended by GPs, diabetes specialist nurses (DSNs), hospitals, pharmacies and airlines. FRÍO® wallets rely on evaporation for cooling. For this purpose, durable and moisture manageable Polycotton and Cambrelle™ fabrics are used. Activated with water, the super-
absorbent polymer crystals contained within the lining of the wallet expand and form an efficient gel cooling pack. The FRIO® maintains safe storage temperatures for in-use insulin and other temperature sensitive medications for up to 28 days, even in constant environmental temperatures of 38°C. The wallets are re-useable, eco-friendly, lightweight and designed to suit all types and makes of insulin pumps, pens, standard refill cartridges and vials. The wallets are also used with eye drop bottles, hypokits, inhalers and adrenaline injectors. FRIO UK Ltd have received the following awards: Design Council’s Millennium Products Award for
creative and innovative products for the new Millennium and DTI’s National Language for Export Awards – Regional Merit Award. For further information: please visit us at Stand F30, Hall 16. Frio UK Ltd Whiteleys Little Treffgarne Haverfordwest SA62 5DY UK Tel: +44 (0)1437 741700 Fax: +44 (0)1437 741781 Email: admin@friouk.com Web: www.friouk.com
22
11 December 2012 A day to remember. WALES medica special A night to celebrate. MediWales is delighted to announce our one-day national health technology conference to be held at the historical Cardiff City Hall in the heart of the Welsh Capital. The event will be a valuable day of briefings and networking for health technology companies and those who work with them.
Plenary Programme
CONFERENCE
Seminar Topics ●
● ● ●
Novel technologies and healthcare trends Improving technology adoption in the NHS Funding and investment expert panel
● ● ● ● ●
For more information please visit the UK HealthTech website or email debbie.laubach@mediwales.com
International trade Finance and funding Research and development Regulatory changes Access to clinical expertise IP and tax
Supported By ● ● ● ● ● ● ●
Medilink UK ABHI One Nucleus The Health KTN Welsh Government UKTI UK Lifescience Industry magazine
www.ukhealthtech.com
The conference will be followed by the MediWales Annual Innovation Awards dinner. Delegates are welcome to register separately for this prestige event.
lifesciences@geldards.com
0844 736 0006
FAST, COMMERCIAL, PRACTICAL GREAT INDUSTRY KNOWLEDGE WITH
Legal 500 2012 Geldards is one of the country’s leading regional law firms. Our clients, in both the private and public sectors, trust us to give them high quality legal advice that is practical, commercially-minded and value for money.
Our dedicated healthcare and life sciences team has a strong track record in dealing with medical technology, know-how licensing, research & development collaborations, commercial contracts and commercial & intellectual property disputes.
Ever had a brilliant idea that you know could succeed... If only someone could turn it into a commercial reality?
Pulse Medical Technologies Ltd (Pulse) was incorporated to design and develop health care products, initially for the pain relief market. The company has grown and expanded its operations into other areas of healthcare, including wound care, using its core technology of Pulsed Electromagnetic Field Therapy (PEMF) as the base.
We even developed a model gut that looks healthy on a balance sheet The first ever truly ‘dynamic’ in vitro system to replicate the biological functions of the human stomach.
PEMF has been used for decades and is FDA approved for various conditions including healing non-union bone fractures, wounds and pain relief. The technology doesn’t have any magnets and has a different mechanism to other treatments e.g. TENS.
Visit us in Hall 16, stand F30 to talk to a member of our team. Our Services:
Products Electronics
Industrial Design
Mechanical Engineering
GPS/GPRS Tracking
Software Design
Rapid Prototyping
Optronics
SCADA/PLC Systems
Value Engineering
RFID
Regulatory Support
Microfluidics
www.gxgroup.com | +44 (0) 1291 673 437
Make it possible
+ WWW.PDRONLINE.CO.UK
MEDICAL DEVICE + EQUIPMENT DESIGN SPECIALISTS Ê PRODUCT DESIGN Ê USABILITY + COMPLIANCE STUDIES Ê GRAPHIC DESIGN + BRANDING Ê PACKAGING DESIGN Ê INNOVATION MANAGEMENT Ê USER OBSERVATION LABORATORY Ê PROTOTYPING + RAPID LOW VOLUME MANUFACTURE Ê KNOWLEDGE TRANSFER Ê RESEARCH THE NATIONAL CENTRE FOR PRODUCT DESIGN + DEVELOPMENT RESEARCH
PDR UWIC WESTERN AVENUE CARDIFF UK CF5 2YB
T +44 (0)29 2041 6725 F +44 (0)29 2041 6973 E INFO@PDRONLINE.CO.UK
+ WWW.PDRONLINE.CO.UK